Literature DB >> 3471268

A multivariate analysis of prognostic factors in chronic myelomonocytic leukaemia according to the FAB criteria.

J M Ribera, F Cervantes, C Rozman.   

Abstract

In an attempt to characterize the prognostic significance of the main initial clinical, haematological and biochemical features of chronic myelomonocytic leukaemia according to the FAB criteria, 29 such patients were analysed by means of univariate and multivariate statistical methods. At the time of the analysis 21 patients had died, with a median survival for the overall series of 8.2 months. The univariate analysis identified three parameters associated with poor prognosis: high monocyte counts, low platelet counts and splenomegaly. When all the initial features were included in a multiple regression model, only high monocyte counts and spleen enlargement retained their unfavourable prognostic influence (P = 0.002 and P = 0.02, respectively). Based on the presence or not of these prognostic factors, two populations of patients with different survival (median survival 5.6 and 16.5 months, respectively, P less than 0.005) could be identified. It seems therefore that monocytic proliferation serves not only as the diagnostic marker for chronic myelomonocytic leukaemia but also as the most important feature in the assessment of the patient's prognosis.

Entities:  

Mesh:

Year:  1987        PMID: 3471268     DOI: 10.1111/j.1365-2141.1987.tb06858.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  5 in total

1.  [Clinical course, morphology and prognosis of chronic myelomonocytic leukemia].

Authors:  U Germing; C Strupp; G Meckenstock; A Giagounidis; H Minning; C Aul
Journal:  Med Klin (Munich)       Date:  1999-09-15

Review 2.  Important features of myelodysplastic syndrome.

Authors:  Wolf K Hofmann; H Phillip Koeffler
Journal:  Int J Hematol       Date:  2002-08       Impact factor: 2.490

Review 3.  Epidemiological features of myelodysplastic syndromes: results from regional cancer surveys and hospital-based statistics.

Authors:  C Aul; A Giagounidis; U Germing
Journal:  Int J Hematol       Date:  2001-06       Impact factor: 2.490

4.  Immunosuppressive treatment in patient with pure red cell aplasia associated with chronic myelomonocytic leukemia: harm or benefit?

Authors:  Saloni Tanna; Celalettin Ustun
Journal:  Int J Hematol       Date:  2009-09-18       Impact factor: 2.490

5.  The incidence of myelodysplastic syndromes in Western Greece is increasing.

Authors:  Christina Avgerinou; Yannis Alamanos; Panagiotis Zikos; Polyxeni Lampropoulou; Maria Melachrinou; Vassiliki Labropoulou; Ioannis Tavernarakis; Anthi Aktypi; Panagiotis Kaiafas; Christos Raptis; Alexandra Kouraklis; Marina Karakantza; Argiris Symeonidis
Journal:  Ann Hematol       Date:  2013-04-10       Impact factor: 3.673

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.